IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

Go back to IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

IGM Biosciences Inc. (IGMS) Reports Q4 Loss of $0.79/sh

March 30, 2021 4:27 PM EDT

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q4 EPS of ($0.79), versus ($0.49) reported last year.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

... More